Chemical activators of Olr1639 can engage diverse cellular pathways to facilitate its functional activation. Forskolin serves as one such activator, directly stimulating adenylyl cyclase to increase intracellular cAMP levels. The surge in cAMP activates protein kinase A (PKA), which can phosphorylate Olr1639, leading to its activation. Similarly, 8-Bromo-cAMP and Dibutyryl-cAMP, both analogs of cAMP, permeate cells to activate PKA, which in turn can phosphorylate and activate Olr1639. This phosphorylation is a post-translational modification that often results in a conformational change in the target protein, altering its activity.
Another route of activation involves the modulation of intracellular calcium levels. Ionomycin, A23187, and Thapsigargin each raise intracellular calcium concentrations, albeit through different mechanisms. Ionomycin and A23187 act as ionophores, facilitating the influx of calcium ions, while Thapsigargin inhibits the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA), disrupting calcium sequestration and thereby increasing cytosolic calcium. The increase in intracellular calcium can activate calcium-sensitive kinases, which are capable of phosphorylating Olr1639, leading to its activation. BAY K8644 similarly activates L-type calcium channels, contributing to an increase in intracellular calcium that can activate kinases capable of phosphorylating Olr1639. Activation of protein kinase C (PKC) through PMA and 4-α-Phorbol is another mechanism by which Olr1639 can be phosphorylated and activated. PKC phosphorylates a wide range of cellular targets, including proteins like Olr1639. Furthermore, Zinc Sulfate may directly bind to Olr1639 or alter the function of metalloproteins within its signaling pathways, triggering its activation. Lastly, Sodium Fluoride and Okadaic Acid hinder the action of phosphatases, which would otherwise dephosphorylate and deactivate proteins. By inhibiting these phosphatases, these chemicals can maintain Olr1639 in a phosphorylated, hence active, state.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium levels which may activate calcium-sensitive kinases that phosphorylate and activate Olr1639. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates PKC which is known to phosphorylate and alter activity of many proteins, possibly including Olr1639. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Activates L-type calcium channels, leading to increased intracellular calcium, which can activate kinases that phosphorylate Olr1639. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
May bind to Olr1639 directly or modify signaling pathways involving metalloproteins, leading to its activation. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $39.00 $45.00 $98.00 | 26 | |
Inhibits phosphatases and can maintain proteins like Olr1639 in a phosphorylated, active state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, which could result in the activation of Olr1639 due to reduced dephosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore that increases intracellular calcium concentration, potentially leading to the activation of Olr1639 through calcium-dependent phosphorylation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
A cAMP analog that activates PKA, which may phosphorylate and activate Olr1639. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Another cAMP analog that permeates cells and activates PKA, potentially leading to the activation of Olr1639. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis by inhibiting SERCA, potentially leading to activation of Olr1639 through increased cytosolic calcium. | ||||||